系统性硬化症患者自报皮肤严重程度与生活质量:PASTUL问卷的多中心验证
该研究在四个英国中心纳入196例系统性硬化症患者,验证患者自评上肢皮肤厚度问卷(PASTUL)与改良Rodnan皮肤评分(mRSS)的相关性,并评估皮肤受累对健康相关生活质量的影响。PASTUL与上肢mRSS在基线、6个月和12个月均良好相关,重测信度好,在弥漫型皮肤亚型中相关性更强,早期病程患者中PASTUL与生活质量中度相关。
要点
- PASTUL与上肢mRSS在基线、6个月、12个月均良好相关(ICC=0.67、0.78、0.62,P<0.001)。
- 重测信度良好(ICC=0.83,P<0.001),完成自评平均耗时5.0分钟(s.d. 3.7)。
- 弥漫型皮肤亚型中PASTUL与上肢mRSS相关性(0.69)强于局限型(0.51),P<0.001。
核心结论
- PASTUL是一种可行的结局工具,可作为SSPRO等评估的补充;皮肤增厚与健康相关生活质量相关,尤其在早期疾病中。
研究设计与样本
- 多中心验证研究,在四个英国中心纳入196例系统性硬化症患者,平均年龄56.4岁(s.d. 13.9),女性80.6%(n=158),平均病程11.9年(s.d. 9.9),局限型皮肤亚型110例(56.1%),弥漫型皮肤亚型81例(41.3%),随访12个月。
主要发现
- PASTUL与上肢mRSS在基线、6个月和12个月均良好相关(ICC=0.67、0.78和0.62,P<0.001)。
- 重测信度良好(ICC=0.83,P<0.001)。
- 弥漫型皮肤亚型中PASTUL与上肢mRSS相关性为0.69,局限型为0.51(P<0.001)。
- 早期疾病(<4年)患者中PASTUL与健康相关生活质量中度相关(r=0.53,P<0.001),全组相关性较弱。
- 完成PASTUL自评的平均时间为5.0分钟(s.d. 3.7)。
关键数值与推荐
- PASTUL规定对八个部位进行皮肤分级,对应改良Rodnan皮肤评分(mRSS)。
- 健康相关生活质量采用EuroQoL五维度五水平(EQ5D5L)和Leeds系统性硬化症生活质量问卷评估。
- 探索了PASTUL与硬皮病皮肤患者报告结局(SSPRO)之间的相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study was to validate the Patient self-Assessment of Skin Thickness in Upper Limb (PASTUL) questionnaire in SSc and assess impact of skin involvement on health-related quality of life (HRQoL). METHODS: Participants were included in four UK centres. PASTUL specifies a grading of skin at eight sites corresponding to the modified Rodnan Skin Score (mRSS). Construct validity was assessed by comparing PASTUL scores with mRSS. HRQoL was evaluated with EuroQoL 5 dimension 5 levels (EQ5D5L) and Leeds SSc QoL questionnaires. Additionally, correlation between PASTUL and Scleroderma Skin Patient-Reported Outcome (SSPRO) was explored. Follow-up was 12 months. RESULTS: In total, 196 participants were included, mean age was 56.4 years (s.d. 13.9), 80.6% female (n = 158), mean disease duration 11.9 years (s.d. 9.9), 110 (56.1%) had lcSSc and 81 (41.3%) dcSSc. PASTUL and upper limb mRSS were well correlated at baseline, 6 and 12 months [intraclass correlation coefficients (ICC) = 0.67, 0.78 and 0.62, P < 0.001]. Test-retest reliability was good (ICC = 0.83, P < 0.001). There was a stronger correlation between PASTUL and upper limb mRSS in dcSSc compared with lcSSc (0.69 vs 0.51, P < 0.001). In participants with early disease (<4 years) PASTUL was moderately correlated with HRQoL (r = 0.53, P < 0.001); correlations were weaker in the whole group. Mean time to do the PASTUL self-assessment was 5.0 min (s.d. 3.7). CONCLUSION: PASTUL is a feasible outcome tool that adds to assessments such as SSPRO. Skin thickening is correlated with HRQoL, particularly in early disease.
引用
- Spierings J, Welsing PMJ, Colak S, et al. Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL. Rheumatology (Oxford). 2025. PMID: 39400748. doi:10.1093/rheumatology/keae561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。